Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAGE-A4 is a cancer/testis antigen normally expressed in germline cells but aberrantly expressed in various tumors. It regulates cell proliferation, inhibits apoptosis, and activates DNA damage tolerance. Its restricted expression profile makes it a promising target for cancer immunotherapy.
Immunotherapies (adoptive T-cell therapy, antibody-based approaches)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma Antigen Gene A Family Member A4 (MAGE-A4).